Download video

TROP2 Breakthrough: New Hope for Renal Medullary Carcinoma Treatment

17 views

Timeless Echoes

8 days ago

TROP2 Breakthrough: New Hope for Renal Medullary Carcinoma Treatment

TROP2 Breakthrough: New Hope for Renal Medullary Carcinoma Treatment

RC48-C016: disitamab vedotin \& toripalimab vs chemotherapy in HER2+ la\/mUC
1:33
RC48-C016: disitamab vedotin \& toripalimab vs chemotherapy in HER2+ la\/mUC
by VJOncology
HER2 Positive Breast Cancer: Everything You Must Know
13:08
HER2 Positive Breast Cancer: Everything You Must Know
by Breast Cancer School for Patients
Breast Cancer Breakthroughs: TROPION-Breast02 Trial
5:11
Breast Cancer Breakthroughs: TROPION-Breast02 Trial
by Susan G. Komen®
The Role of the TROP2 Biomarker in Cancer
4:15
The Role of the TROP2 Biomarker in Cancer
by Debbie's Dream Foundation: Curing Stomach Cancer
Ongoing lung cancer trials and the potential of Trop2 biomarker at BTOG 2025
0:54
Ongoing lung cancer trials and the potential of Trop2 biomarker at BTOG 2025
by VJOncology
Correlation between Trop2 and pCR in patients with HER2-positive early breast cancer
1:17
Correlation between Trop2 and pCR in patients with HER2-positive early breast cancer
by VJOncology
PI3K: A New Target in Breast Cancer Treatment
6:04
PI3K: A New Target in Breast Cancer Treatment
by Cancer Treatment Updates
Defining the Future Role of TROP2-Directed Antibody-Drug Conjugates in Non-Small Cell Lung Cancer
17:45
Defining the Future Role of TROP2-Directed Antibody-Drug Conjugates in Non-Small Cell Lung Cancer
by Research To Practice
Clinical Trials for Pancreatic Cancer
21:15
Clinical Trials for Pancreatic Cancer
by Let's Win Pancreatic Cancer
2025 Breast Cancer Treatment: I-SPY2 Trial’s Lobular Chemotherapy Breakthrough
5:30
2025 Breast Cancer Treatment: I-SPY2 Trial’s Lobular Chemotherapy Breakthrough
by OncologyTube
TROP2: A Promising Breast Cancer Drug Target
3:48
TROP2: A Promising Breast Cancer Drug Target
by Susan G. Komen®
The OncoAlert Weekly Round Up October 3 to 9, 2025. TROPION-Breast02 , IMforte
4:44
The OncoAlert Weekly Round Up October 3 to 9, 2025. TROPION-Breast02 , IMforte
by OncoAlert 360
Navigating the clinical impact of TROP2-targeting in NSCLC
56:43
Navigating the clinical impact of TROP2-targeting in NSCLC
by Touch Medical Media
TROP2-Targeting ADCs as New Tools in the TNBC and HR+\/HER2- Breast Cancer Treatment Arsenal
51:40
TROP2-Targeting ADCs as New Tools in the TNBC and HR+\/HER2- Breast Cancer Treatment Arsenal
by PeerView Oncology
Health Tips - HER2-Positive Breast Cancer
3:12
Health Tips - HER2-Positive Breast Cancer
by Premier Health
32 month follow-up of MOUNTAINEER: tucatinib and trastuzumab in HER2+ mCRC
1:11
32 month follow-up of MOUNTAINEER: tucatinib and trastuzumab in HER2+ mCRC
by VJOncology
Current and Future Role of TROP2-Directed Antibody-Drug Conjugates in Non-Small Cell Lung Cancer
24:48
Current and Future Role of TROP2-Directed Antibody-Drug Conjugates in Non-Small Cell Lung Cancer
by Research To Practice
Anti-HER2 Mechanisms of Approved HER2 Inhibitors
5:05
Anti-HER2 Mechanisms of Approved HER2 Inhibitors
by HMP Education
Overcoming resistance to trastuzumab deruxtecan in HER2-low cancers
1:42
Overcoming resistance to trastuzumab deruxtecan in HER2-low cancers
by VJOncology